Biodegradable polymer support containing bioactive material and manufacturing method therefor
US-2024299626-A1 · Sep 12, 2024 · US
US9889238B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9889238-B2 |
| Application number | US-50697309-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2009 |
| Priority date | Jul 21, 2009 |
| Publication date | Feb 13, 2018 |
| Grant date | Feb 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A biodegradable polymeric stent made from poly(L-lactide) and a low concentration of L-lactide monomer is disclosed. The concentration of L-lactide is adjusted to provide a degradation behavior that is suitable for different treatment applications including coronary, peripheral, and nasal.
Opening claim text (preview).
What is claimed is: 1. A stent for treating a diseased section of a blood vessel, comprising: a polymeric scaffolding comprising poly(L-lactide) and particles of L-lactide monomer mixed or dispersed within the poly(L-lactide), wherein the size of the particles is between 100 nm and 1000 nm, wherein the crystallinity of the poly(L-lactide) is between 20-50%, wherein the L-lactide monomer is between 0.05 and 0.5 wt % of the scaffolding, and wherein the number average molecular weight of the poly(L-lactide) is between 60,000 and 300,000, relative to polystyrene standards. 2. The stent of claim 1 , wherein the scaffolding comprises greater than 95 wt % poly(L-lactide). 3. The stent of claim 1 , wherein the scaffolding is composed of a pattern of struts, the pattern including a plurality of cylindrical rings connected by linking struts. 4. The stent of claim 3 , wherein the struts have a rectangular cross-section, the cross-sectional area being between 20,000 and 25,000 μm 2 . 5. The stent of claim 1 , wherein the scaffolding has polymer chain orientation induced by radial expanding a tube between 200-500% and forming the stent therefrom.
Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
Plastics other than composite materials · CPC title
involving non-metallic material, e.g. isolators · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.